Palatin Technologies
PTN
#10927
Rank
A$16.18 M
Marketcap
A$9.09
Share price
9.81%
Change (1 day)
-53.60%
Change (1 year)

EPS for Palatin Technologies (PTN)

EPS in 2023 (TTM): A-$4.41

According to Palatin Technologies's latest financial reports the company's current EPS (TTM) is A-$10.95. In 2022 the company made an earnings per share (EPS) of A-$4.54 an increase over its 2021 EPS that were of A-$5.31.

EPS history for Palatin Technologies from 1998 to 2023

Annual EPS

Year EPS Change
2023 (TTM)A-$4.41-2.78%
2022A-$4.54-14.48%
2021A-$5.3133.09%
2020A-$3.99-161.11%
2019A$6.52-4909.03%
2018A-$0.14-102.88%
2017A$4.71-143.33%
2016A-$10.87-9.09%
2015A-$11.963200%
2014A-$0.36-93.33%
2013A-$5.44-69.39%
2012A-$17.7610.16%
2011A-$16.12-58.04%
2010A-$38.42-394.44%
2009A$13.05-121.18%
2008A-$61.61-10.53%
2007A-$68.86-57.78%
2006A-$163.099.76%
2005A-$148.595.13%
2004A-$141.35-35%
2003A-$217.45-38.14%
2002A-$351.55-15.65%
2001A-$416.7918.56%
2000A-$351.55-41.44%
1999A-$600.31-42.88%
1998A-$1,051

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$9.69-188.54%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$9.68-188.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
A$10.22-193.38%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
A-$0.33-96.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$14.51-232.58%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
A$7.00-163.97%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
A-$0.75-93.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
A-$0.32-97.09%๐Ÿ‡บ๐Ÿ‡ธ USA